Home » Topics » Regulatory » Patents

Patents
RSS

ET antagonists disclosed by Merck KGaA

May 27, 1997

Glaxo Wellcome discloses heteroaromatic protein tyrosine kinase inhibitors

May 27, 1997

Pyrimidine derivatives from Roche for psychotic disorders

May 26, 1997

5-HT reuptake inhibitors disclosed by NeuroSearch

May 26, 1997

MAO-A and/or MAO-B inhibitors described by Synthelabo

May 26, 1997

EAA antagonists reported by Pharmacia & Upjohn

May 26, 1997

Chem. Pharm. Forschungs-Gesellschaft describes COX-2 inhibitors

May 26, 1997

Lilly describes new agents for postmenopausal syndrome

May 26, 1997

Anti-H. pylori agents disclosed by Roussel Morishita

May 26, 1997

Orthosomycins discovered by Schering-Plough

May 26, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 5, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...